Content begins here

RePORT International Resources

View all training resources.

247 items found
Funding

NIDA: Program Project Grant Applications (P01 Clinical Trial Optional)

The National Institute on Drug Abuse (NIDA) seeks collaborative research by multi-disciplinary teams to address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, medications development, health services, HIV/AIDS and co-occurring opportunistic infections (e.g., viral hepatitis C, tuberculosis, sexually transmitted infections) and associated consequences in people who use or misuse substances or have a substance use disorder, or other research areas relevant to substance use, misuse, or use disorders. NEXT SUBMISSION DEADLINE: 9/7/2025
Research Tools

NIH Extramural Nexus (News)

The NIH Extramural Nexus is the NIH's official platform for updates on grants policies, application processes, and funding news. Hosted within the NIH Grants & Funding website, it serves as a centralized resource for researchers, administrators, and institutions navigating the NIH extramural research landscape. The platform offers timely information on policy changes, application tips, and new resources, ensuring the research community stays informed and compliant with NIH requirements.
Research Tools

NIH Grants Process for Beginners: Webinar Resources Available

Learn the basics with NIH Grants Process: A Walk-Through for Beginners Tune in for answers to your questions in the NIH Expert Q&A Panel: Part 1 Test your knowledge with Submission Policies: You Make the Call More questions and answers in the NIH Expert Q&A Panel: Part 2 Take our panelists’ advice: Grant Application Tips from NIH Experts
Webinar
Research Tools

NIH: DAIDS Learning Portal

Most important training for any investigator would be HSP/GCP where they need to learn and understand how Ethical conduct of research is done and why it is important. I have pasted various links below that cover all the topics extensively. DAIDS learning portal, HANC network , DAIDS score manual have good training modules .
Research Tools

NIH: DAIDS SCORE Manual

This document provides a detailed list of source documentation requirements during the conduct of a clinical trial. Source documentation refers to the record of the participant before, during and after a trial.
Funding

NIH: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant. All applications must be within the scope of the mission of one of the Institutes/Centers listed in the notice. Application DEADLINE: Multiple dates, see announcement.
Training & Conferences

NIH: Pragmatic and Group-Randomized Trials in Public Health and Medicine

This online course is presented by Dr. David M. Murray, the NIH Associate Director for Prevention and Director of Office of Disease Prevention. This course, updated in September 2024, is meant to help researchers design trials involving groups or clusters.
Online
Funding

Notice of Special Interest (NOSI): Investigating TB Pathogenesis and Host Immunity to Preserve Lung Health After TB

Contact: Robert Mahon Robert.Mahon@nih.gov Objective: The scientific objectives of this new initiative are to 1) better understand the types and pathogenesis of long-term lung damage resulting from pulmonary tuberculosis (TB) and the role of the host immune response, and 2) identify ways to mitigate lung damage during TB treatment through host-directed therapy. There is no set-aside funding for this NOSI.
GrantTuberculosis
Training & Conferences

OpenWHO Website

WHO online learning platform
Online
Additional TB Resources

Partners In Health: Turmoil, TB Care, & Taking Action

A discussion including leading TB experts, authors, and thought leaders to shed light on how actions from the Trump administration affect patients and the long fight against TB.
Tuberculosis
Funding

Pasteur Network Internship for Infectious Disease Research

The Calmette & Yersin Programme internship grants aim to support Pasteur Network scientists, whether they are students, technicians, engineers or researchers to carry out an internship within the network. The purpose of the internship os to reinforce the intern's skills in his/her field of research and to reinforce the capacities of the institute of origin. Any subject covered by a Pasteur Network institute laboratory: research into infectious diseases (infectious physiopathology, immunology, microbiology, epidemiology, virology, parasitology) and public health activities (diagnosis, monitoring, resistance, etc.). It must be consistent with the candidate's research area. Calendar for 2025 Selection: 5th of March 20th of June (deadline extended) 17th of September 10th of December
Funding

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

Expiration Date: 6 September 2025 This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Notice of Funding Opportunity requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH and CDC Institutes and Centers (ICs) based on their scientific missions.
Funding

Public Health Laboratory Fellowship Program: an APHL-CDC Initiative

Applications are now being accepted and reviewed on a rolling basis. There is no deadline to apply! The Public Health Laboratory Fellowship Program aims to strengthen laboratory systems and workforce needs by developing the next generation of public health scientists! Thus, the fellowship program will focus on training participants in alignment with established laboratory core competencies and offer experiential learning opportunities across laboratory science focus areas. Fellowship terms are one year, with a possible extension for a second year, depending on the fellowship and funding availability. ​​ APHL offers flexible start dates to meet fellow's and mentor's needs. ​ Fellows will work on projects specific to a laboratory science focus area that will support public health, One Health, and other initiatives. Below are examples of the different focus areas fellows could be matched with and placed into: Bioinformati​​​cs​ Biorisk Management Emergency Preparedness and Response Environmental Health Food Safety Infectious Disease Informatics Laboratory Operations and Support Services Quality Management Radiochemistry Ronald H. Laessig Newborn Screening​ Fellows are placed in host laboratories which include state and local public health laboratories and non-federal academic, agricultural, chemical, environmental, food safety and veterinary laboratories. Regardless of host laboratory type, the fellow will still be trained in techniques and competencies that are transferrable to a career in public health laboratory science.
Additional TB Resources

Qure.ai Artificial Intelligence for Health Systems Strengthening

Presented by Shibu Vijayan
A.I.Health Systems
Research Tools

Radiant Moms online survey

Radiant Moms online survey
Survey
Additional TB Resources

RePORT India: Bridging Research Gaps in TB - India's Path to Elimination

This webinar, held as part of the INDO-US TB Programme, brings together leading experts to spotlight the critical research gaps that must be addressed to help India achieve its TB elimination goals by 2025. It covers key focus areas from diagnostics and treatment innovations to operational research and policy implementation strategies.
TuberculosisWebinar
Additional TB Resources

RePORT International Global Research Forum on Artificial Intelligence in TB

These 2 presentation are part of the RePORT International Global Research Forum. Presentation 1: Results of the RICC Survey on AI: Are we ready for the future? by Sanjana Gandikota, Masters of Global Public Health Student, Rutgers School of Public Health Presentaion 2: Making Scientific Publications More Accessible, Along with the ChatGPT Application by Dr. Mariana Araújo-Pereira, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative
Tuberculosis
Training & Conferences

RePORT International Virtual Annual Meeting

Please see below for registration details and preliminary agenda for the virtual RePORT International Annual Meeting in September. The registration deadline of August 10th has been extended. Meeting Details: Dates: September 17-19, 2025 Format: Virtual (Online) Platform: Zoom Webinar Start time: 7 am ET each day Important Guidelines: Registration is mandatory. Each participant must register individually. The meeting link you receive after registration is exclusive to the registrant and cannot be shared. No chatbots/AI tools or recordings are permitted during the meeting. Close captioning can be used, if needed. If you have any questions, please reach out to dm1471@njms.rutgers.edu or tbricc@njms.rutgers.edu
Tuberculosis
Additional TB Resources

RePORT International: Decoding TB - Advancements & Future Directions in Diagnostic & Pathogenesis Biomarkers

Presented by Bruno Andrade
TuberculosisWebinar
Additional TB Resources

RePORT International: Ending TB: The Critical Role of Determinants

Lecture by Farai Mavhunga, Unit Head for the Vulnerable Populations, Communities and Comorbidities (VCC) unit, WHO Global Tuberculosis Program, Geneva.
LectureTuberculosis
1 2 6 7 8 12 13